Tumor exosomes: cellular postmen of cancer diagnosis and personalized therapy

References

• 1 Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262(19), 9412–9420 (1987).
  Medline CASGoogle Scholar
• 2 Urbanelli L, Magini A, Buratta S et al. Signaling pathways in exosomes biogenesis, secretion and fate. Genes 4(2), 152–170 (2013).
  MedlineGoogle Scholar
• 3 Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200(4), 373–383 (2013).
  Medline CASGoogle Scholar
• 4 Li XB, Zhang ZR, Schluesener HJ, Xu SQ. Role of exosomes in immune regulation. J. Cell. Mol. Med. 10(2), 364–375 (2006).
  Medline CASGoogle Scholar
• 5 Colombo M, Moita C, Van Niel G et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J. Cell Sci. 126(Pt 24), 5553–5565 (2013).
  Medline CASGoogle Scholar
• 6 Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell. Dev. Biol. 30, 255–289 (2014).
  Medline CASGoogle Scholar
• 7 Frydrychowicz M, Kolecka-Bednarczyk A, Madejczyk M, Yasar S, Dworacki G. Exosomes – structure, biogenesis and biological role in non-small-cell lung cancer. Scand. J. Immunol. 81(1), 2–10 (2015).
  Medline CASGoogle Scholar
• 8 Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14(3), 195–208 (2014).
  Medline CASGoogle Scholar
• 9 Ostrowski M, Carmo NB, Krumeich S et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12(1), 19–30; sup pp 11–13 (2010).
  Medline CASGoogle Scholar
• 10 Parolini I, Federici C, Raggi C et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284(49), 34211–34222 (2009).
  Medline CASGoogle Scholar
• 11 Zhang HG, Grizzle WE. Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. Am. J. Pathol. 184(1), 28–41 (2014).
  Medline CASGoogle Scholar
• 12 Testa JS, Apcher GS, Comber JD, Eisenlohr LC. Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin. J. Immunol. 185(11), 6608–6616 (2010).
  Medline CASGoogle Scholar
• 13 Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu. Rev. Physiol. 77, 13–27 (2015).
  Medline CASGoogle Scholar
• 14 Guo L, Guo N. Exosomes: potent regulators of tumor malignancy and potential bio-tools in clinical application. Crit. Rev. Oncol. Hematol. 95(3), 346–358 (2015).
  MedlineGoogle Scholar
• 15 Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820(7), 940–948 (2012).
  Medline CASGoogle Scholar
• 16 Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 32(3–4), 623–642 (2013).
  Medline CASGoogle Scholar
• 17 Cossetti C, Lugini L, Astrologo L, Saggio I, Fais S, Spadafora C. Soma-to-germline transmission of RNA in mice xenografted with human tumor cells: possible transport by exosomes. PLoS ONE 9(7), e101629 (2014).
  MedlineGoogle Scholar
• 18 Kahlert C, Melo SA, Protopopov A et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J. Biol. Chem. 289(7), 3869–3875 (2014).
  Medline CASGoogle Scholar
• 19 Demory Beckler M, Higginbotham JN, Franklin JL et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol. Cell. Proteomics 12(2), 343–355 (2013).
  MedlineGoogle Scholar
• 20 Al-Nedawi K, Meehan B, Micallef J et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumor cells. Nat. Cell Biol. 10(5), 619–624 (2008).
  Medline CASGoogle Scholar
• 21 Ciravolo V, Huber V, Ghedini GC et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J. Cell. Physiol. 227(2), 658–667 (2012).
  Medline CASGoogle Scholar
• 22 Li X, Xin S, He Z et al. microRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma. Cell. Physiol. Biochem. 33(6), 1631–1642 (2014).
  Medline CASGoogle Scholar
• 23 Cappellesso R, Tinazzi A, Giurici T et al. Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions. Cancer Cytopathol. 122(9), 685–693 (2014).
  Medline CASGoogle Scholar
• 24 Putz U, Howitt J, Doan A et al. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci. Signal. 5(243), ra70 (2012).
  MedlineGoogle Scholar
• 25 Aspe JR, Diaz Osterman CJ, Jutzy JM, Deshields S, Whang S, Wall NR.Enhancement of gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant. J. Extracell. Vesicles 3, doi:10.3402/jev.v3.23244 (2014).
  MedlineGoogle Scholar
• 26 Pap E, Pallinger E, Falus A. The role of membrane vesicles in tumorigenesis. Crit. Rev. Oncol. Hematol. 79(3), 213–223 (2011).
  MedlineGoogle Scholar
• 27 Khan S, Aspe JR, Asumen MG et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br. J. Cancer 100(7), 1073–1086 (2009).
  Medline CASGoogle Scholar
• 28 Federici C, Petrucci F, Caimi S et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS ONE 9(2), e88193 (2014).
  MedlineGoogle Scholar
• 29 Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S. Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics 15(2–3), 260–271 (2015).
  Medline CASGoogle Scholar
• 30 Lim PK, Bliss SA, Patel SA et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res. 71(5), 1550–1560 (2011).
  Medline CASGoogle Scholar
• 31 Lee TH, D'asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer – the emerging science of cellular ‘debris’. Semin. Immunopathol. 33(5), 455–467 (2011).
  MedlineGoogle Scholar
• 32 Nazarenko I, Rana S, Baumann A et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 70(4), 1668–1678 (2010).
  Medline CASGoogle Scholar
• 33 Sharghi-Namini S, Tan E, Ong LL, Ge R, Asada HH. Dll4-containing exosomes induce capillary sprout retraction in a 3D microenvironment. Sci. Rep. 4, 4031 (2014).
  MedlineGoogle Scholar
• 34 Park JE, Tan HS, Datta A et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell. Proteomics 9(6), 1085–1099 (2010).
  Medline CASGoogle Scholar
• 35 Franzen CA, Blackwell RH, Todorovic V et al. Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes. Oncogenesis 4, e163 (2015).
  Medline CASGoogle Scholar
• 36 Greening DW, Gopal SK, Mathias RA et al. Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression. Semin. Cell Dev. Biol. 40, 60–71 (2015).
  Medline CASGoogle Scholar
• 37 D'asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J. Oncogenic extracellular vesicles in brain tumor progression. Front. Physiol. 3, 294 (2012).
  MedlineGoogle Scholar
• 38 Fong MY, Zhou W, Liu L et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat. Cell Biol. 17(2), 183–194 (2015).
  Medline CASGoogle Scholar
• 39 Milane L, Singh A, Mattheolabakis G, Suresh M, Amiji MM. Exosome mediated communication within the tumor microenvironment. J. Control. Release 21, 278–294 (2015).
  Google Scholar
• 40 Taylor DD, Gercel-Taylor C. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin. Immunopathol. 33(5), 441–454 (2011).
  Medline CASGoogle Scholar
• 41 Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J. Mol. Med. (Berl.) 91(4), 431–437 (2013).
  Medline CASGoogle Scholar
• 42 Ichim TE, Zhong Z, Kaushal S et al. Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J. Transl. Med. 6, 37 (2008).
  MedlineGoogle Scholar
• 43 Bhatia A, Kumar Y. Cellular and molecular mechanisms in cancer immune escape: a comprehensive review. Expert Rev. Clin. Immunol. 10(1), 41–62 (2014).
  Medline CASGoogle Scholar
• 44 Marleau AM, Chen CS, Joyce JA, Tullis RH. Exosome removal as a therapeutic adjuvant in cancer. J. Transl. Med. 10, 134 (2012).
  Medline CASGoogle Scholar
• 45 Monleon I, Martinez-Lorenzo MJ, Monteagudo L et al. Differential secretion of Fas ligand- or APO₂ ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 167(12), 6736–6744 (2001).
  Medline CASGoogle Scholar
• 46 Andreola G, Rivoltini L, Castelli C et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195(10), 1303–1316 (2002).
  Medline CASGoogle Scholar
• 47 Huber V, Fais S, Iero M et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 128(7), 1796–1804 (2005).
  Medline CASGoogle Scholar
• 48 Manterola L, Guruceaga E, Gallego Perez-Larraya J et al. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol. 16(4), 520–527 (2014).
  Medline CASGoogle Scholar
• 49 Skog J, Wurdinger T, Van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumor growth and provide diagnostic biomarkers. Nat. Cell Biol. 10(12), 1470–1476 (2008).
  Medline CASGoogle Scholar
• 50 Zhang J, Li S, Li L et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 13(1), 17–24 (2015).
  Medline CASGoogle Scholar
• 51 Silva J, Garcia V, Zaballos A et al. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur. Respir. J. 37(3), 617–623 (2011).
  Medline CASGoogle Scholar
• 52 Cheng G. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Adv. Drug Deliv. Rev. 81, 75–93 (2015).
  Medline CASGoogle Scholar
• 53 Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10(1), 42–46 (2009).
  Medline CASGoogle Scholar
• 54 Khan S, Jutzy JM, Valenzuela MM et al. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS ONE 7(10), e46737 (2012).
  Medline CASGoogle Scholar
• 55 Mitchell PJ, Welton J, Staffurth J et al. Can urinary exosomes act as treatment response markers in prostate cancer? J. Transl. Med. 7, 4 (2009).
  MedlineGoogle Scholar
• 56 Bryant RJ, Pawlowski T, Catto JW et al. Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 106(4), 768–774 (2012).
  Medline CASGoogle Scholar
• 57 Ravelli A, Reuben JM, Lanza F et al. Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. Tumor Biol. doi:10.1007/s13277-015-3944-7 (2015).
  Google Scholar
• 58 Choi DS, Park JO, Jang SC et al. Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 11(13), 2745–2751 (2011).
  Medline CASGoogle Scholar
• 59 Matsumura T, Sugimachi K, Iinuma H et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br. J. Cancer 113(2), 275–281 (2015).
  Medline CASGoogle Scholar
• 60 Wang M, Zhao C, Shi H et al. Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br. J. Cancer 110(5), 1199–1210 (2014).
  Medline CASGoogle Scholar
• 61 Eldh M, Olofsson Bagge R, Lasser C et al. MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma. BMC Cancer 14, 962 (2014).
  MedlineGoogle Scholar
• 62 Keller S, Konig AK, Marme F et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 278(1), 73–81 (2009).
  Medline CASGoogle Scholar
• 63 Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 9, 244 (2009).
  MedlineGoogle Scholar
• 64 Taylor DD, Gercel-Taylor C. microRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110(1), 13–21 (2008).
  Medline CASGoogle Scholar
• 65 Szajnik M, Derbis M, Lach M et al. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy. Gynecol. Obstetr. 4(Suppl.), 3 (2013).
  Google Scholar
• 66 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011).
  Medline CASGoogle Scholar
• 67 Van Deun J, Mestdagh P, Sormunen R et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell. Vesicles 3, doi:10.3402/jev.v3.24858 (2014).
  MedlineGoogle Scholar
• 68 Lobb RJ, Becker M, Wen SW et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell. Vesicles 4, 27031 (2015).
  MedlineGoogle Scholar
• 69 Lozano-Ramos I, Bancu I, Oliveira-Tercero A et al. Size-exclusion chromatography-based enrichment of extracellular vesicles from urine samples. J. Extracell. Vesicles 4, 27369 (2015).
  MedlineGoogle Scholar
• 70 Hong CS, Muller L, Boyiadzis M, Whiteside TL. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS ONE 9(8), e103310 (2014).
  MedlineGoogle Scholar
• 71 Pospichalova V, Svoboda J, Dave Z et al. Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. J. Extracell. Vesicles 4, 25530 (2015).
  MedlineGoogle Scholar
• 72 Shin H, Han C, Labuz JM et al. High-yield isolation of extracellular vesicles using aqueous two-phase system. Sci. Rep. 5, 13103 (2015).
  Medline CASGoogle Scholar
• 73 Dudani JS, Gossett DR, Tse HT, Lamm RJ, Kulkarni RP, Carlo DD. Rapid inertial solution exchange for enrichment and flow cytometric detection of microvesicles. Biomicrofluidics 9(1), 014112 (2015).
  MedlineGoogle Scholar
• 74 Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14(11), 1891–1900 (2014).
  Medline CASGoogle Scholar
• 75 Santana SM, Antonyak MA, Cerione RA, Kirby BJ. Microfluidic isolation of cancer-cell-derived microvesicles from hetergeneous extracellular shed vesicle populations. Biomed. Microdevices 16(6), 869–877 (2014).
  Medline CASGoogle Scholar
• 76 Chen C, Skog J, Hsu CH et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10(4), 505–511 (2010).
  Medline CASGoogle Scholar
• 77 Im H, Shao H, Park YI et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat. Biotechnol. 32(5), 490–495 (2014).
  Medline CASGoogle Scholar
• 78 Rho J, Chung J, Im H et al. Magnetic nanosensor for detection and profiling of erythrocyte-derived microvesicles. ACS Nano 7(12), 11227–11233 (2013).
  Medline CASGoogle Scholar
• 79 Cvjetkovic A, Lotvall J, Lasser C. The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles. J. Extracell. Vesicles 3, doi:10.3402/jev.v3.23111 (2014).
  MedlineGoogle Scholar
• 80 Li J, Liu K, Liu Y et al. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat. Immunol. 14(8), 793–803 (2013).
  Medline CASGoogle Scholar
• 81 Zhang Z, Wang C, Li T, Liu Z, Li L. Comparison of ultracentrifugation and density gradient separation methods for isolating Tca8113 human tongue cancer cell line-derived exosomes. Oncol. Lett. 8(4), 1701–1706 (2014).
  Medline CASGoogle Scholar
• 82 Logozzi M, De Milito A, Lugini L et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4(4), e5219 (2009).
  MedlineGoogle Scholar
• 83 Ban JJ, Lee M, Im W, Kim M. Low pH increases the yield of exosome isolation. Biochem. Biophys. Res. Commun. 461(1), 76–79 (2015).
  Medline CASGoogle Scholar
• 84 Ko J, Carpenter E, Issadore D. Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices. Analyst doi:10.1039/c5an01610j (2015) (Epub ahead of print).
  Google Scholar
• 85 Im H, Shao H, Weissleder R, Castro CM, Lee H. Nano-plasmonic exosome diagnostics. Expert Rev. Mol. Diagn. 15(6), 725–733 (2015).
  Medline CASGoogle Scholar
• 86 Yoshioka Y, Kosaka N, Konishi Y et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat. Commun. 5, 3591 (2014).
  MedlineGoogle Scholar
• 87 Exosome Diagnostics. Personalized Precision Healthcare. www.exosomedx.com.
  Google Scholar
• 88 Caris Life Sciences: Precision Medicine for Cancer Care. www.carislifesciences.eu.
  Google Scholar
• 89 ExoCan Healthcare Technology Pvt. Ltd. www.exocanhealthcare.com.
  Google Scholar
• 90 De Mello RA, Madureira P, Carvalho LS, Araujo A, O'brien M, Popat S EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer. Pharmacogenomics 14(14), 1765–1777 (2013).
  CASGoogle Scholar
• 91 Brinton LT, Sloane HS, Kester M, Kelly KA. Formation and role of exosomes in cancer. Cell. Mol. Life Sci. 72(4), 659–671 (2015).
  Medline CASGoogle Scholar
• 92 An T, Qin S, Xu Y et al. Exosomes serve as tumor markers for personalized diagnostics owing to their important role in cancer metastasis. J. Extracell. Vesicles 4, 27522 (2015).
  MedlineGoogle Scholar
• 93 Shao H, Chung J, Lee K et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat. Commun. 6, 6999 (2015).
  Medline CASGoogle Scholar
• 94 Hong CS, Muller L, Whiteside TL, Boyiadzis M. Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia. Front. Immunol. 5, 160 (2014).
  MedlineGoogle Scholar
• 95 Boukouris S, Mathivanan S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin. Appl. 9(3–4), 358–367 (2015).
  Medline CASGoogle Scholar
• 96 Thakur BK, Zhang H, Becker A et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 24(6), 766–769 (2014).
  Medline CASGoogle Scholar
• 97 Villagrasa A, Alvarez PJ, Osuna A, Garrido JM, Aranega A, Rodriguez-Serrano F. Exosomes Derived from Breast Cancer Cells, Small Trojan Horses? J. Mammary Gland Biol. Neoplasia 19(3–4), 303–313 (2014).
  MedlineGoogle Scholar
• 98 Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol. Cancer 14, 133 (2015).
  MedlineGoogle Scholar